products sercives ordering301.html ordering

NDT202 FD Cresyl Violet Solution
(500 ml)
Two concentrations are offered:
NDT202-1 Regular strength price: $105.20
NDT202-2 Double-strength price: $143.30
NDT202 cresyl violet solution, made from cresyl violet acetate certified by the BIOLOGICAL STAIN COMMISSION and with a step by step user's manual printed on the bottle, is specifically designed for easy use in all types of laboratories. This solution is formulated and extensively tested for the staining of nerve tissue. Cresyl violet imparts a violet color to nuclear chromatin and Nissl substances. This solution is excellent for visualizing neuronal cell bodies and glial nuclei.

NDT202-2 is also excellent for counterstaining of immunostained sections from both neuronal and non-neuronal tissues (see above).

References using this product

  1. Bishop C, Tessmer JL, Ullrich T, Rice KC, and Walker PD: Serotonin 5-HT2A receptors underlie increased motor behaviors induced in dopamine-depleted rats by intrastriatal 5-HT2A/2C agonism. J. Pharmacol. Exp. Ther. 310: 687-694, 2004.

  2. Kreipke CW, and Walker PD: NMDA Receptor blockage attenuates locomotion elicited by intrastriatal dopamine D1-receptor stimulation. Synapse  53: 28-35, 2004.

  3. Nakamura NH, Rosell DR, Akama KT and McEwen BS: Estrogen and ovariectomy regulate mRNA and protein of glutamic acid decarboxylases and cation-chloride cotransporters in the adult rat hippocampus. Neuroendocrinology 80:308-323, 2004.

  4. Kostich WA, Grzanna R, Lu NZ and Largent BL: Immunohistochemical visualization of corticotropin-releasing factor type 1 (CRF1) receptors in monkey brain.J. Comp. Neurol. 478:111-125, 2004.

  5. Clabough EBD and Zeitlin SO: Deletion of the triplet repeat encoding polyglutamine within the mouse Huntington's disease gene results in subtle behavioral/motor phenotypes in vivo and elevated levels of ATP with cellular senescence in vitro. Human Molecular Genetics 15:607-623, 2006.

  6. Balan IS, Fiskum G, Hazelton J, Cotto-Cumba C and Rosenthal RE: Oximetry-guided reoxygenation improves neurological outcome after experimental cardiac arrest. Stroke doi:10.1161/01.STR.0000248455.73785.b1, 2006.

2013-2018 @ NeuroDigiTech All Rights Reserved.